Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria

Journal of Clinical Investigation

Volumn 122, Issue 6, 2012, Pages 2289-2300

  Tan, Kai Soo ^a,e   Lee, Kok Onn ^b   Low, Kee Chung ^a   Gamage, Akshamal Mihiranga ^a   Liu, Yichun ^c   Tan, Gek Yen Gladys ^c   Koh, Hui Qi Vanessa ^a,d   Alonso, Sylvie ^a,d   Gan, Yunn Hwen ^a,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Dept Medicine Endocrinol Diabet   (Singapore)

^c DSO NATIONAL LABORATORIES   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; GAMMA INTERFERON; GLUTATHIONE; INTERLEUKIN 12P70; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; BURKHOLDERIA PSEUDOMALLEI; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MELIOIDOSIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RISK FACTOR; SALMONELLA ENTERICA; TUBERCULOSIS; TYPHOID FEVER;

ADULT; AGED; ANIMALS; BURKHOLDERIA PSEUDOMALLEI; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DISEASE SUSCEPTIBILITY; FEMALE; GLUTATHIONE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; MALE; MELIOIDOSIS; MICE; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; TOLL-LIKE RECEPTORS;

EID: 84861833415     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI57817     Document Type: Article

References (52)

1. Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9(12):737-746.
2. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med. 1999;341(15):1127-1133. (Pubitemid 29466226)
3. Renard C, Van Obberghen E. Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models? Diabetes Metab. 2006;32(1):15-29. (Pubitemid 43872592)
4. Yamagishi SI, Nakamura K, Matsui T, Takenaka K, Jinnouchi Y, Imaizumi T. Cardiovascular disease in diabetes. Mini Rev Med Chem. 2006;6(3):313-318.
5. Pop-Busui R, Sima A, Stevens M. Diabetic neuropathy and oxidative stress. Diabetes Metab Res Rev. 2006;22(4):257-273. (Pubitemid 44070502)
6. Moutschen MP, Scheen AJ, Lefebvre PJ. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabetes Metab. 1992;18(3):187-201.
7. White NJ. Melioidosis. Lancet. 2003;361(9370): 1715-1722. (Pubitemid 36577448)
8. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev. 2005;18(2):383-416. (Pubitemid 40548298)
9. Simpson AJH, Newton PN, Chierakul W, Chaowagul W, White NJ. Diabetes mellitus, insulin, and melioidosis in Thailand. Clin Infect Dis. 2003;36(5):e71-e72.
10. Hassan M, et al. Incidence, risk factors and clinical epidemiology of melioidosis: a complex socioecological emerging infectious disease in the Alor Setar region of Kedah, Malaysia. BMC Infect Dis. 2010;10:302.
11. Chanchamroen S, Kewcharoenwong C, Susaengrat W, Ato M, Lertmemongkolchai G. Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects. Infect Immun. 2009;77(1):456-463.
12. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2010;11(2):136-140.
13. Santanirand P, Harley VS, Dance DA, Drasar BS, Bancroft GJ. Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect Immun. 1999;67(7):3593-3600. (Pubitemid 29291534)
14. Breitbach K, Klocke S, Tschernig T, van Rooijen N, Baumann U, Steinmetz I. Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice. Infect Immun. 2006;74(11):6300- 6309. (Pubitemid 44657411)
15. Oppmann B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13(5):715-725.
16. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813-820. (Pubitemid 34000785)
17. Murata Y, Ohteki T, Koyasu S, Hamuro J. IFN-gamma and pro-inflammatory cytokine production by antigen-presenting cells is dictated by intracellular thiol redox status regulated by oxygen tension. Eur J Immunol. 2002;32(10):2866-2873. (Pubitemid 35238179)
18. Alam K, Ghousunnissa S, Nair S, Valluri VL, Mukhopadhyay S. Glutathione-redox balance regulates c-rel-driven IL-12 production in macrophages: possible implications in antituberculosis immunotherapy. J Immunol. 2010;184(6):2918-2929.
19. Williams NL, Morris JL, Rush C, Govan BL, Ketheesan N. Impact of streptozotocin-induced diabetes on functional responses of dendritic cells and macrophages towards Burkholderia pseudomallei. FEMS Immunol Med Microbiol. 2011;61(2):218-227.
20. Hodgson KA, Morris JL, Feterl ML, Govan BL, Ketheesan N. Altered macrophage function is associated with severe Burkholderia pseudomallei infection in a murine model of type 2 diabetes. Microbes Infect. 2011;13(14-15):1177-1184.
21. Drew R, Miners JO. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation. Biochem Pharmacol. 1984;33(19):2989-2994. (Pubitemid 14044593)
22. Villa P, Saccani A, Sica A, Ghezzi P. Glutathione protects mice from lethal sepsis by limiting inflammation and potentiating host defense. J Infect Dis. 2002;185(8):1115-1120. (Pubitemid 34297769)
23. Lauw FN, et al. Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis. J Infect Dis. 1999;180(6):1878-1885.
24. Liu B, Koo GC, Yap EH, Chua KL, Gan YH. Model of differential susceptibility to mucosal Burkholderia pseudomallei infection. Infect Immun. 2002;70(2):504-511. (Pubitemid 34083807)
25. Koh GCKW, et al. Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis. Clin Infect Dis. 2011;52(6):717-725.
26. Millman AC, Salman M, Dayaram YK, Connell ND, Venketaraman V. Natural killer cells, glutathione, cytokines, and innate immunity against Mycobacterium tuberculosis. J Interferon Cytokine Res. 2008;28(3):153-165. (Pubitemid 351380151)
27. De Mattia G, Laurenti O, Bravi C, Ghiselli A, Iuliano L, Balsano F. Effect of aldose reductase inhibition on glutathione redox status in erythrocytes of diabetic patients. Metabolism. 1994;43(8):965-968. (Pubitemid 24249397)
28. Bravi MC, et al. Insulin decreases intracellular oxidative stress in patients with type 2 diabetes mellitus. Metabolism. 2006;55(5):691-695. (Pubitemid 44316511)
29. Peterson JD, Herzenberg LA, Vasquez K, Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci U S A. 1998;95(6):3071-3076. (Pubitemid 28135856)
30. Koike Y, et al. Glutathione redox regulates airway hyperresponsiveness and airway inflammation in mice. Am J Respir Cell Mol Biol. 2007;37(3):322-329. (Pubitemid 350067611)
31. Mazzeo D, et al. Thiol antioxidants inhibit the formation of the interleukin-12 heterodimer: a novel mechanism for the inhibition of IL-12 production. Cytokine. 2002;17(6):285-293.
32. van de Vosse E, Ottenhoff THM. Human host genetic factors in mycobacterial and Salmonella infection: lessons from single gene disorders in IL-12/IL-23-dependent signaling that affect innate and adaptive immunity. Microbes Infect. 2006;8(4):1167-1173.
33. Kuwajima S, Sato T, Ishida K, Tada H, Tezuka H, Ohteki T. Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation. Nat Immunol. 2006;7(7):740-746. (Pubitemid 43905873)
34. Carroll HP, Paunovic V, Gadina M. Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity. Rheumatology. 2008;47(9):1269-1277.
35. Haque A, et al. Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J Infect Dis. 2006;193(3):370-379. (Pubitemid 43122336)
36. Lertmemongkolchai G, Cai G, Hunter CA, Bancroft GJ. Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J Immunol. 2001;166(2):1097-1105. (Pubitemid 32060268)
37. Tippayawat P, et al. Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei. PLoS Negl Trop Dis. 2009;3(4):e407.
38. Corthay A. A three-cell model for activation of naïve T helper cells. Scand J Immunol. 2006;64(2):93-96. (Pubitemid 44034312)
39. Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem. 2009;390(3):191-214.
40. Zipser Y, Piade A, Kosower NS. Erythrocyte thiol status regulates band 3 phosphotyrosine level via oxidation/reduction of band 3-associated phosphotyrosine phosphatase. FEBS Lett. 1997;406(1-2):126-130. (Pubitemid 27156973)
41. Mustelin T, Vang T, Bottini N. Protein tyrosine phosphatases and the immune response. Nat Rev Immunol. 2005;5(1):43-57. (Pubitemid 40070330)
42. Cayota A, Vuillier F, Gonzalez G, Dighiero G. CD4+ lymphocytes from HIV-infected patients display impaired CD45-associated tyrosine phosphatase activity which is enhanced by anti-oxidants. Clin Exp Immunol. 1996;104(1):11-17. (Pubitemid 26106038)
43. Urata Y, et al. Long exposure to high glucose concentration impairs the responsive expression of gamma-glutamylcysteine synthetase by interleukin-1beta and tumor necrosis factor-alpha in mouse endothelial cells. J Biol Chem. 1996;271(25):15146-15152. (Pubitemid 26194994)
44. Loske C, et al. Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J Neural Transm. 1998;105(8-9):1005-1015. (Pubitemid 28539843)
45. Deuther-Conrad W, Loske C, Schinzel R, Dringen R, Riederer P, Münch G. Advanced glycation endproducts change glutathione redox status in SH-SY5Y human neuroblastoma cells by a hydrogen peroxide dependent mechanism. Neurosci Lett. 2001;312(1):29-32. (Pubitemid 32907545)
46. Nencioni L, et al. Influenza A virus replication is dependent on an antioxidant pathway that involves GSH and Bcl-2. FASEB J. 2003;17(6):758-760.
47. Cheng AC. Melioidosis: advances in diagnosis and treatment. Curr Opin Infect Dis. 2010;23(6):554-559.
48. White NJ, Dance DA, Chaowagul W, Wattanagoon Y, Wuthiekanun V, Pitakwatchara N. Halving of mortality of severe melioidosis by ceftazidime. Lancet. 1989;2(8665):697-701. (Pubitemid 19243112)
49. Cheng AC, Stephens DP, Anstey NM, Currie BJ. Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis. Clin Infect Dis. 2004;38(1):32-37. (Pubitemid 38045870)
50. Cheng AC, et al. A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis. 2007;45(3):308-314. (Pubitemid 47101026)
51. Hii CS, Sun GW, Goh JWK, Lu J, Stevens MP, Gan YH. Interleukin-8 induction by Burkholderia pseudomallei can occur without Toll-like receptor signaling but requires a functional type III secretion system. J Infect Dis. 2008;197(11):1537-1547. (Pubitemid 351706484)
52. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-408. (Pubitemid 34164012)